Citations

Clear

4847 citation(s) found for "Yu, Eric".

De novo coding variants in the AGO1 gene cause a neurodevelopmental disorder with intellectual disability
Schalk, Audrey , Cousin, Margot A. , Dsouza, Nikita R., Challman, Thomas D. , Wain, Karen E. , Powis, Zöe , Minks, Kelly Q., Trimouille, Aurélien , Lasseaux, Eulalie , Michaud, Vincent , Van‐Gils, Julien , Spataro, Nino , Gabau, Elizabeth, Stolerman, Elliot , Washington, Camerun , Louie, Ray, Lanpher, Brendan C. , Kemppainen, Jennifer L., Innes, Micheil, Kooy, R. Frank , Goldenberg, Alice, Lecoquierre, François , Vera, Gabriella , Sheidley, Beth Rosen , Achkar, Christelle Moufawad El , Park, Meredith, Hamdan, Fadi F. , Michaud, Jacques L. , Lewis, Ann J., Zweier, Christiane , Wagner, Matias , Weigand, Heike, Journel, Hubert, Keren, Boris , Passemard, Sandrine , Mignot, Cyril , Brilstra, Eva H. , Itzikowitz, Gina, O’Heir, Emily , Allen, Jake, Donald, Kirsten A. , Korf, Bruce R. , Skelton, Tammi, Rudy, Natasha L. , Dobyns, William B. , Foss, Kimberly , Bosanko, Katherine A. , Alembik, Yves, Durand, Benjamin , Mau‐Them, Frédéric Tran , Ranza, Emmanuelle , Blanc, Xavier , Torti, Erin , Millan, Francisca , Dameron, Amy, Tokita, Mari, Zimmermann, Michael T. , Klee, Eric W. , Piton, Amélie , Gérard, Bénédicte , Ruiz, Anna , Stolerman, Elliot , Kooy, Frank , Lecoquierre, Francois , Reis, André , Wagner, Matias , Passemard, Sandrine , Tran Mau-Them, Frederic , Klee, Eric W , Piton, Amelie , Zimmermann, Michael T , Lacombe, Didier , Angelini, Chloé , Louie, Raymond J. , Meuwissen, Marije E. C. , Goldenberg, Alice , Diderich, Karin E. M. , Reis, André , Gassen, Koen L.I. van , Thompson, Michelle L. , Robin, Nathaniel H. , Zárate, Yuri A. , Antonarakis, Stylianos E. , McWalter, Kirsty

Mayo Clinic

Journal of Medical Genetics | December 20, 2021 | Volume: 59 | Issue: 10 | Pages: 965-975

10.1136/jmedgenet-2021-107751 | PMID 34930816 Get It

Background High-impact pathogenic variants in more than a thousand genes are involved in Mendelian forms of neurodevelopmental disorders (NDD). Methods This study describes the molecular and clinical characterisation of 28 probands with NDD harbouring heterozygous AGO1 coding variants, occurring de novo for all those whose transmission could have been verified (26/28). Results A total of 15 unique variants leading to amino acid changes or deletions were identified: 12 missense variants, two in-frame deletions of one codon, and one canonical splice variant leading to a deletion of two amino acid residues. Recurrently identified variants were present in several unrelated individuals: p.(Phe180del), p.(Leu190Pro), p.(Leu190Arg), p.(Gly199Ser), p.(Val254Ile) and p.(Glu376del). AGO1 encodes the Argonaute 1 protein, which functions in gene-silencing pathways mediated by small non-coding RNAs. Three-dimensional protein structure predictions suggest that these variants might alter the flexibility of the AGO1 linker domains, which likely would impair its function in mRNA processing. Affected individuals present with intellectual disability of varying severity, as well as speech and motor delay, autistic behaviour and additional behavioural manifestations. Conclusion Our study establishes that de novo coding variants in AGO1 are involved in a novel monogenic form of NDD, highly similar to the recently reported AGO2 -related NDD.
Studying APOE ɛ4 Allele Dose Effects with a Univariate Morphometry Biomarker
Wang, Gang, Initiative, for the Alzheimer’s Disease Neuroimaging, Zhou, Wenju, Kong, Deping, Qu, Zongshuai, Ba, Maowen, Hao, Jinguang, Yao, Tao, Dong, Qunxi, Su, Yi, Reiman, Eric M., Caselli, Richard J., Chen, Kewei, Wang, Yalin, Wang, Gang, Initiative, for the Alzheimer’s Disease Neuroimaging, Zhou, Wenju, Kong, Deping, Qu, Zongshuai, Ba, Maowen, Hao, Jinguang, Yao, Tao, Dong, Qunxi, Su, Yi, Reiman, Eric M., Caselli, Richard J., Chen, Kewei, Wang, Yalin

Mayo Clinic

Journal of Alzheimer's Disease | December 17, 2021 | Volume: 85 | Issue: 3 | Pages: 1233-1250

10.3233/jad-215149 | PMID 34924383 Get It

Background: A univariate neurodegeneration biomarker (UNB) based on MRI with strong statistical discrimination power would be highly desirable for studying hippocampal surface morphological changes associated with APOE ɛ4 genetic risk for AD in the cognitively unimpaired (CU) population. However, existing UNB work either fails to model large group variances or does not capture AD induced changes. Objective: We proposed a subspace decomposition method capable of exploiting a UNB to represent the hippocampal morphological changes related to the APOE ɛ4 dose effects among the longitudinal APOE ɛ4 homozygotes (HM, N = 30), heterozygotes (HT, N = 49) and non-carriers (NC, N = 61). Methods: Rank minimization mechanism combined with sparse constraint considering the local continuity of the hippocampal atrophy regions is used to extract group common structures. Based on the group common structures of amyloid-β (Aβ) positive AD patients and Aβ negative CU subjects, we identified the regions-of-interest (ROI), which reflect significant morphometry changes caused by the AD development. Then univariate morphometry index (UMI) is constructed from these ROIs. Results: The proposed UMI demonstrates a more substantial statistical discrimination power to distinguish the longitudinal groups with different APOE ɛ4 genotypes than the hippocampal volume measurements. And different APOE ɛ4 allele load affects the shrinkage rate of the hippocampus, i.e., HM genotype will cause the largest atrophy rate, followed by HT, and the smallest is NC. Conclusion: The UMIs may capture the APOE ɛ4 risk allele-induced brain morphometry abnormalities and reveal the dose effects of APOE ɛ4 on the hippocampal morphology in cognitively normal individuals.
Whole genome sequencing–based copy number variations reveal novel pathways and targets in Alzheimer's disease
Chen, Ming , Wang, Minghui , Neff, Ryan , Wang, Erming , Reddy, Joseph S. , Allen, Mariet , Ertekin‐Taner, Nilüfer , Jager, Philip L. De , Bennett, David A. , Haroutunian, Vahram , Schadt, Eric E. , Ming, Chen , Bennett, David A. , Wang, Qian , Shen, Qi , Wang, Xue, Zhang, Bin

Mayo Clinic

Alzheimer's & Dementia | December 17, 2021 | Volume: 18 | Issue: 10 | Pages: 1846-1867

10.1002/alz.12507 | PMID 34918867 Get It

AbstractIntroductionA few copy number variations (CNVs) have been reported for Alzheimer's disease (AD). However, there is a lack of a systematic investigation of CNVs in AD based on whole genome sequencing (WGS) data.MethodsWe used four methods to identify consensus CNVs from the WGS data of 1,411 individuals and further investigated their functional roles in AD using the matched transcriptomic and clinicopathological data.ResultsWe identified 3,012 rare AD‐specific CNVs whose residing genes are enriched for cellular glucuronidation and neuron projection pathways. Genes whose mRNA expressions are significantly correlated with common CNVs are involved in major histocompatibility complex class II receptor activity. Integration of CNVs, gene expression, and clinical and pathological traits further pinpoints a key CNV that potentially regulates immune response in AD.DiscussionWe identify CNVs as potential genetic regulators of immune response in AD. The identified CNVs and their downstream gene networks reveal novel pathways and targets for AD.
Allograft prosthetic composite reconstruction using a reverse total shoulder arthroplasty for failed oncologic proximal humerus reconstruction
Houdek, Matthew T. , Rose, Peter S. , Elhassan, Bassem T. , Barlow, Jonathan D. , Sanchez-Sotelo, Joaquin, Houdek, Matthew T , Wagner, Eric R. , Elhassan, Bassem T. , Sánchez‐Sotelo, Joaquín

Mayo Clinic

Journal of Surgical Oncology | December 16, 2021 | Volume: 125 | Issue: 4 | Pages: 775-781

10.1002/jso.26772 | PMID 34913481 Get It

AbstractIntroductionEndoprosthetic or allograft reconstruction are the preferred reconstruction techniques for proximal humeral bone tumors. Failure of these reconstructions may occur, but historically revision is performed rarely due to the lack of reliable options. Reverse shoulder arthroplasty with an allograft prosthetic composite (rAPC) may provide a revision option. The purpose of the current study was to evaluate our institutional outcome of these procedures.MethodsEleven (6 male, 5 female) patients (mean age 51 ± 17 years) underwent revision of a failed oncologic reconstruction of the proximal humerus utilizing a rAPC. The most common indication for revision was subluxation (n = 6) and the most common previous implant was an endoprosthesis (n = 5).ResultsRevision resulted in improvements in shoulder elevation (39° vs. 62°, p = 0.02), external rotation (13° vs. 25°, p = 0.04), American Shoulder and Elbow Surgeons score (39 vs. 58, p = 0.004) and Musculoskeletal Tumor Society Scores (51% vs 69%, p = 0.002). There were 2 re‐revision procedures performed. One for an allograft fracture and one for allograft resorption and loosening.ConclusionsRevision with a rAPC can effectively restore patient function. Due to the complexity of the cases, we advocate for these procedures to be performed by subspecialty upper extremity surgeons trained in complex revision shoulder arthroplasty.
An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels
León, José de , Schoretsanitis, Georgios , Smith, Robert L. , Molden, Espen , Solismaa, Anssi , Seppälä, Niko , Kopeček, Miloslav , Švancer, Patrik , Olmos, I. Cánovas , Ricciardi, Carina , García, Celso Iglesias , Iglesias-Alonso, Ana , Ruan, Can‐Jun , Wang, Chuanyue , Wang, Gang , Tang, Yi‐lang , Kim, Yong Sik , Kim, Se Hyun , Rajkumar, Anto P. , González‐Esquivel, Dinora F. , Jung–Cook, Helgi , Verdoux, Hélène , Quilès, Clélia , Sanz, Emílio J. , Cuevas, Carlos De las , Cohen, Dan , Schulte, Peter F.J. , Yağcıoğlu, A. Elif Anıl , Chopra, Nitin , McCollum, Betsy , Shelton, Charles , Cotes, Robert O. , Kaithi, Arun R., Kane, John M. , Farooq, Saeed , Ng, Chee H. , Bilbily, John , Hiemke, Christoph , López‐Jaramillo, Carlos , McGrane, Ian R. , Lana, Fernando , Arrojo, Manuel , Rădulescu, Flavian Ștefan , Seifritz, Erich , Every‐Palmer, Susanna , Bebawi, Emmanuel , Bhattacharya, Rahul , Kelly, Deanna L. , Otsuka, Yuji , Lazáry, Judit , Torres, Rafael , Yécora, Agustín, Motuca, Mariano , Chan, Sherry Kit Wa , Berardis, Domenico De , Adebayo, Richard A. , Кирилочев, О.О. , Soloviev, A. G. , Fountoulakis, Konstantinos Ν. , Wilkowska, Alina , Cubała, Wiesław Jerzy , Ayub, Muhammad , Silva, Alzira , Bonelli, Raphael M., Crespo‐Facorro, Benedicto , Temmingh, Henk , Decloedt, Eric , Pedro, Maria Rosel , Tsukahara, Masaru , Gründer, Gerhard , Čelofiga, Andreja , Ristić, Dragana Ignjatović , Ortiz, Bruno Bertolucci , Elkis, Hélio , Siskind, Dan , Masmoudi, R. , Saffian, Shamin Mohd , Leung, Jonathan G. , Buckley, P.F. , Freudenreich, Oliver , Müller, Daniel J. , de Leon, Jose , Olmos, Ismael , Iglesias-Garcia, Celso , Spina, Edoardo , Ruan, Can-Jun , Wang, Chuan-Yue , Tang, Yi-Lang , Lin, Shih-Ku , Lane, Hsien-Yuan , Kim, Yong Sik , Kim, Se Hyun , Rajkumar, Anto P , González-Esquivel, Dinora F , Jung-Cook, Helgi , Baptista, Trino , Rohde, Christopher , Nielsen, Jimmi , Verdoux, Hélène , Quiles, Clelia , Sanz, Emilio J , De Las Cuevas, Carlos , Cohen, Dan , Schulte, Peter F J , Ertuğrul, Aygün , Anıl Yağcıoğlu, A Elif , Chopra, Nitin , McCollum, Betsy , Shelton, Charles , Cotes, Robert O , Kane, John M , Farooq, Saeed , Ng, Chee H , Bilbily, John , Hiemke, Christoph , López-Jaramillo, Carlos , McGrane, Ian , Lana, Fernando , Eap, Chin B , Every-Palmer, Susanna , Bousman, Chad A , Bebawi, Emmanuel , Bhattacharya, Rahul , Kelly, Deanna L , Otsuka, Yuji , Lazary, Judit , Motuca, Mariano , Chan, Sherry K W , Zolezzi, Monica , Ouanes, Sami , De Berardis, Domenico , Grover, Sandeep , Procyshyn, Ric M , Adebayo, Richard A , Kirilochev, Oleg O , Soloviev, Andrey , Fountoulakis, Konstantinos N , Wilkowska, Alina , Cubała, Wiesław J , Ayub, Muhammad , Silva, Alzira , Villagrán-Moreno, José M , Crespo-Facorro, Benedicto , Temmingh, Henk , Decloedt, Eric , Pedro, Maria R , Takeuchi, Hiroyoshi , Tsukahara, Masaru , Gründer, Gerhard , Sagud, Marina , Celofiga, Andreja , Ignjatovic Ristic, Dragana , Ortiz, Bruno B , Elkis, Helio , Pacheco Palha, António J , LLerena, Adrián , Fernandez-Egea, Emilio , Siskind, Dan , Weizman, Abraham , Masmoudi, Rim , Mohd Saffian, Shamin , Leung, Jonathan G , Buckley, Peter F , Marder, Stephen R , Citrome, Leslie , Freudenreich, Oliver , Correll, Christoph Ulrich , Müller, Daniel J , Kopecek, Miloslav , Arrojo-Romero, Manuel , Schoretsanitis, Georgios , Rohde, Christopher , Nielsen, Jimmi , Bousman, Chad , LLerena, Adrián , Citrome, Leslie

Mayo Clinic

Pharmacopsychiatry | December 15, 2021 | Volume: 55 | Issue: 02 | Pages: 73-86

10.1055/a-1625-6388 | PMID 34911124 Get It

Abstract This international guideline proposes improving clozapine package inserts worldwide by using ancestry-based dosing and titration. Adverse drug reaction (ADR) databases suggest that clozapine is the third most toxic drug in the United States (US), and it produces four times higher worldwide pneumonia mortality than that by agranulocytosis or myocarditis. For trough steady-state clozapine serum concentrations, the therapeutic reference range is narrow, from 350 to 600 ng/mL with the potential for toxicity and ADRs as concentrations increase. Clozapine is mainly metabolized by CYP1A2 (female non-smokers, the lowest dose; male smokers, the highest dose). Poor metabolizer status through phenotypic conversion is associated with co-prescription of inhibitors (including oral contraceptives and valproate), obesity, or inflammation with C-reactive protein (CRP) elevations. The Asian population (Pakistan to Japan) or the Americas’ original inhabitants have lower CYP1A2 activity and require lower clozapine doses to reach concentrations of 350 ng/mL. In the US, daily doses of 300–600 mg/day are recommended. Slow personalized titration may prevent early ADRs (including syncope, myocarditis, and pneumonia). This guideline defines six personalized titration schedules for inpatients: 1) ancestry from Asia or the original people from the Americas with lower metabolism (obesity or valproate) needing minimum therapeutic dosages of 75–150 mg/day, 2) ancestry from Asia or the original people from the Americas with average metabolism needing 175–300 mg/day, 3) European/Western Asian ancestry with lower metabolism (obesity or valproate) needing 100–200 mg/day, 4) European/Western Asian ancestry with average metabolism needing 250–400 mg/day, 5) in the US with ancestries other than from Asia or the original people from the Americas with lower clozapine metabolism (obesity or valproate) needing 150–300 mg/day, and 6) in the US with ancestries other than from Asia or the original people from the Americas with average clozapine metabolism needing 300–600 mg/day. Baseline and weekly CRP monitoring for at least four weeks is required to identify any inflammation, including inflammation secondary to clozapine rapid titration.
Abdominal Wall Vascularized Composite Allotransplantation: A Scoping Review
Bustos, Valeria P. , Escandón, Joseph M. , Santamaría, Eric , Ciudad, Pedro , Forte, Antonio J. , Leckenby, Jonathan I. , Langstein, Howard N. , Manrique, Oscar J. , Forte, Antonio Jorge , Escandón, Joseph M

Mayo Clinic

Journal of Reconstructive Microsurgery | December 15, 2021 | Volume: 38 | Issue: 06 | Pages: 481-490

10.1055/s-0041-1740121 | PMID 34905782 Get It

AbstractBackground Abdominal wall vascularized composite allotransplantation (AW-VCA) is a novel reconstructive technique used for large abdominal wall defects in combination with intestinal transplantation (ITx) or multivisceral abdominal transplantation (MVTx). Since the introduction of this procedure, several studies have been published reporting their experience. This study aims to present a scoping review looking at all available evidence-based medicine information to understand the most current surgical techniques and clinical outcomes.Methods This scoping review followed the Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) extension for scoping reviews checklist. A comprehensive research strategy of several databases was conducted.Results A total of 31 studies were included in this review, which comprised animal, cadaveric, and human studies. In human studies, four surgical techniques with high flap survival rates and low complication rates were found. In cadaveric studies, it was shown that the use of iliofemoral cuff-based flaps provided adequate tissue perfusion to the abdominal wall graft. Also, the use of thoracolumbar nerves have been described to provide functionality to the AW-VCA and prevent long-term muscle atrophy.Conclusion AW-VCA is a safe and efficient alternative for patients with large and complex abdominal wall defects. The future holds a promising evolution of a functional AW-VCA, though surgeons must face and overcome the challenge of distorted anatomy frequently present in this population. Forthcoming studies with a better level of evidence are required to evaluate functionality and differences between surgical techniques.
UME-to-GME PandEMonium in COVID-19: Large-Scale Implementation of a Virtual ACGME Milestone-Based Curriculum for Senior Medical Students Matched Into Emergency Medicine
McLean, Mary E., Cotarelo, Adrian A., Huls, Thomas A., Husain, Abbas, Hillman, Emily A., Cygan, Lukasz D., Archer, Linette O., Beck-Esmay, Jennifer, Burke, Shannon M., Carrick, Angela I., Chen, Angela S., Hyde, Robert J., Karalius, Vytas P., Lee, Eric, Park, Joel C., Pugliese, Angela M., Wilbanks, Morgan D., Young, Amanda, Kulkarni, Miriam L., Karalius, Vytas P. , Husain, Abbas , McLean, Mary E., Cotarelo, Adrian A., Huls, Thomas A., Husain, Abbas, Hillman, Emily A., Cygan, Lukasz D., Archer, Linette O., Beck-Esmay, Jennifer, Burke, Shannon M., Carrick, Angela I., Chen, Angela S., Hyde, Robert J., Lee, Eric, Park, Joel C., Pugliese, Angela M., Wilbanks, Morgan D., Young, Amanda, Kulkarni, Miriam L.

Mayo Clinic

Journal of Graduate Medical Education | December 14, 2021 | Volume: 13 | Issue: 6 | Pages: 848-857

10.4300/jgme-d-21-00620.1 | PMID 35070098 Get It

ABSTRACT Background The COVID-19 pandemic displaced newly matched emergency medicine “pre-interns” from in-person educational experiences at the end of medical school. This called for novel remote teaching modalities. Objective This study assesses effectiveness of a multisite Accreditation Council for Graduate Medical Education (ACGME) sub-competency-based curricular implementation on Slack during the first wave of the COVID-19 pandemic in the United States. Methods Emergency medicine residency programs were recruited via national organization listservs. Programs designated instructors to manage communications and teaching for the senior medical students who had matched to their programs (pre-interns) in spring/summer 2020. Pre- and post-surveys of trainees and instructors assessed perceived preparedness for residency, perceived effectiveness of common virtual educational modalities, and concern for the pandemic's effects on medical education utilizing a Likert scale of 1 (very unconcerned) to 5 (very concerned). Data were analyzed using descriptive statistics and the t test. Results Of 276 possible residency programs, 28 enrolled. Of 324 possible pre-interns, 297 (91.7%) completed pre-surveys in April/May and 249 (76.9%) completed post-surveys in June/July. The median weeks since performing a physical examination was 8 (IQR 7–12), since attending in-person didactics was 10 (IQR 8–15) and of rotation displacement was 4 (IQR 2–6). Perceived preparedness increased both overall and for 14 of 21 ACGME Milestone topics taught. Instructors reported higher mean concern (4.32, 95% CI 4.23–4.41) than pre-interns (2.88, 95% CI 2.74–3.02) regarding the pandemic's negative effects on medical education. Conclusions Pre-interns reported improvements in residency preparedness after participating in this ACGME sub-competency-based curriculum on Slack.
Toward Individualized Prediction of Response to Methotrexate in Early Rheumatoid Arthritis: A Pharmacogenomics‐Driven Machine Learning Approach
Myasoedova, Elena , Athreya, Arjun P. , Crowson, Cynthia S. , Davis, John M. , Walchak, Robert C., Bongartz, Tim, Tak, Paul P. , Vollenhoven, Ronald van , Padyukov, Leonid , Emery, Paul , Morgan, Ann W , Wang, Liewei , Weinshilboum, Richard M. , Matteson, Eric L. , Carlson, Erin, Tak, Paul P , Padyukov, Leonid , Emery, Paul , Morgan, Ann , Matteson, Eric L , Myasoedova, Elena , Davis, John M , Warrington, Kenneth J. , Carlson, Erin E. , Kalari, Krishna R. , Weinshilboum, Richard M.

Mayo Clinic

Arthritis Care & Research | December 13, 2021 | Volume: 74 | Issue: 6 | Pages: 879-888

10.1002/acr.24834 | PMID 34902228 Get It

Objective To test the ability of machine learning (ML) approaches with clinical and genomic biomarkers to predict methotrexate treatment response in patients with early rheumatoid arthritis (RA). Methods Demographic, clinical, and genomic data from 643 patients of European ancestry with early RA (mean age 54 years; 70% female) subdivided into a training (n = 336) and validation cohort (n = 307) were used. The genomic data comprised 160 single‐nucleotide polymorphisms (SNPs) previously associated with RA or methotrexate metabolism. Response to methotrexate monotherapy was defined as good or moderate by the European Alliance of Associations for Rheumatology (EULAR) response criteria at the 3‐month follow‐up. Supervised ML methods were trained with 5 repeats and 10‐fold cross‐validation using the training cohort. Prediction performance was validated in the independent validation cohort. Results Supervised ML methods combining age, sex, smoking, rheumatoid factor, baseline Disease Activity Score in 28 joints (DAS28) scores and 160 SNPs predicted EULAR response at 3 months with the area under the receiver operating curve of 0.84 ( P = 0.05) in the training cohort and achieved a prediction accuracy of 76% ( P = 0.05) in the validation cohort (sensitivity 72%, specificity 77%). Intergenic SNPs rs12446816, rs13385025, rs113798271, and ATIC (rs2372536) had variable importance above 60.0 and along with baseline DAS28 scores were among the top predictors of methotrexate response. Conclusion Pharmacogenomic biomarkers combined with baseline DAS28 scores can be useful in predicting response to methotrexate in patients with early RA. Applying ML to predict treatment response holds promise for guiding effective RA treatment choices, including timely escalation of RA therapies.
Performance of a Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography–Derived Risk-Stratification Tool for High-risk and Very High-risk Prostate Cancer
Martin, Ting , Savjani, Ricky R. , Pollom, Erqi L., Karnes, R. Jeffrey , Wong, J.K. , Motterle, Giovanni , Tosoian, Jeffrey J. , Klein, Eric A. , Stish, Bradley J. , Dess, Robert T. , Spratt, Daniel E. , Pilar, Avinash , Levin-Epstein, Rebecca , Wedde, Trude B. , Lilleby, Wolfgang , Fiano, Ryan , Stock, Richard G. , Demanes, D. Jeffrey, Huland, Hartwig , Martin, Santiago, Krauss, Daniel , Abu‐Isa, Eyad, Schwen, Zeyad , Pisansky, Thomas M. , Choo, C. Richard, Greco, Stephen , Deville, Curtiland , McNutt, Todd , DeWeese, Theodore L. , Ross, Ashley E. , Ciezki, Jay P. , Nickols, Nicholas G. , Bhat, Prashant , Shabsovich, David , Juarez, Jesus E. , Chong, Natalie, Kupelian, Patrick A. , Reiter, Robert E. , Steinberg, Michael L. , Elashoff, David , Horwitz, Eric M. , Tendulkar, Rahul D. , Czernin, Johannes, Gafita, Andrei , Romero, Tahmineh , Calais, Jérémie , Kishan, Amar U. , Davis, Brian J. , Deville, Curtiland , Spratt, Daniel E , Dess, Robert T , Klein, Eric A , Ma, Ting Martin , Calais, Jeremie , Xiang, Michael H. , Grogan, Tristan , Trock, Bruce J , Reddy, Chandana A. , Merrick, Gregory Stephen , Moran, Brian Joseph , Tran, Phuoc T , Martínez‐Monge, Rafael , Alam, Ridwan , Song, Daniel Y. , Boutros, Paul C. , Rettig, Matthew B. , Zaorsky, Nicholas G. , Berlin, Alejandro , Tward, Jonathan D. , Tilki, Derya

Mayo Clinic

JAMA Network Open | December 13, 2021 | Volume: 4 | Issue: 12 | Pages: e2138550

10.1001/jamanetworkopen.2021.38550 | PMID 34902034 Get It

Robotic-Assisted vs Nonrobotic-Assisted Minimally Invasive Transforaminal Lumbar Interbody Fusion: A Cost-Utility Analysis
Moniz‐Garcia, Diogo , Akinduro, Oluwaseun O., Biase, Gaetano De, Sousa-Pinto, Bernardo, Jerreld, Daniel J., Dholakia, Ruchita, Borah, Bijan, Nottmeier, Eric, Deen, H. Gordon, Fox, W. Christopher, Bydon, Mohamad, Chen, Selby, Quinones-Hinojosa, Alfredo, Abode-Iyamah, Kingsley, Biase, Gaetano De , Sousa‐Pinto, Bernardo , De Biase, Gaetano , Garcia, Diogo Moniz , Akinduro, Oluwaseun O., Jerreld, Daniel J., Dholakia, Ruchita, Borah, Bijan, Nottmeier, Eric, Deen, H. Gordon, Fox, W. Christopher, Bydon, Mohamad, Chen, Selby, Quinones-Hinojosa, Alfredo, Abode-Iyamah, Kingsley

Mayo Clinic

Neurosurgery | December 13, 2021 | Volume: 90 | Issue: 2 | Pages: 192-198

10.1227/neu.0000000000001779 | PMID 35023874 Get It

BACKGROUND: Management of degenerative disease of the spine has evolved to favor minimally invasive techniques, including nonrobotic-assisted and robotic-assisted minimally invasive transforaminal lumbar interbody fusion (MIS-TLIF). Value-based spending is being increasingly implemented to control rising costs in the US healthcare system. With an aging population, it is fundamental to understand which procedure(s) may be most cost-effective. OBJECTIVE: To compare robotic and nonrobotic MIS-TLIF through a cost-utility analysis. METHODS: We considered direct medical costs related to surgical intervention and to the hospital stay, as well as 1-yr utilities. We estimated costs by assessing all cases involving adults undergoing robotic surgery at a single institution and an equal number of patients undergoing nonrobotic surgery, matched by demographic and clinical characteristics. We adopted a willingness to pay of $50 000/quality-adjusted life year (QALY). Uncertainty was addressed by deterministic and probabilistic sensitivity analyses. RESULTS: Costs were estimated based on a total of 76 patients, including 38 undergoing robot-assisted and 38 matched patients undergoing nonrobot MIS-TLIF. Using point estimates, robotic surgery was projected to cost $21 546.80 and to be associated with 0.68 QALY, and nonrobotic surgery was projected to cost $22 398.98 and to be associated with 0.67 QALY. Robotic surgery was found to be more cost-effective strategy, with cost-effectiveness being sensitive operating room/materials and room costs. Probabilistic sensitivity analysis identified robotic surgery as cost-effective in 63% of simulations. CONCLUSION: Our results suggest that at a willingness to pay of $50 000/QALY, robotic-assisted MIS-TLIF was cost-effective in 63% of simulations. Cost-effectiveness depends on operating room and room (admission) costs, with potentially different results under distinct neurosurgical practices.